Literature DB >> 12515322

17beta-estradiol effect on the extracellular concentration of amino acids in the glutamate excitotoxicity model in the rat.

Marie-Françoise Ritz1, Petra Schmidt, Aminadav Mendelowitsch.   

Abstract

Estrogen has demonstrated a neuroprotective role in a rat model of glutamate excitotoxicity and other neurodegenerative disorders. We studied the effect of 17beta-estradiol on glutamate-induced increases in amino acids levels (aspartate, histidine, taurine and GABA) in the rat cortex. Local perfusion of glutamate produced a transient increase of aspartate, histidine, taurine and GABA in the extracellular fluid. Pretreatment with 17beta-estradiol significantly reduced the increases of taurine and moderately attenuated that of histidine, whereas aspartate and GABA releases were not modified. The effect of 17beta-estradiol on histidine release was reversed by the antiestrogen tamoxifen, suggesting a receptor-dependent mechanism. Good correlations between the volumes of the glutamate-induced lesions and the extracellular concentrations of taurine and aspartate were observed. These findings suggest that the attenuation of the glutamate-induced release of taurine by 17beta-estradiol may participate in the neuroprotective effects of 17beta-estradiol and that increased levels of aspartate and taurine are markers for the severity of the glutamate-induced cortical lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515322     DOI: 10.1023/a:1021695213099

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

Review 1.  Glutamate neurotoxicity and diseases of the nervous system.

Authors:  D W Choi
Journal:  Neuron       Date:  1988-10       Impact factor: 17.173

2.  Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors.

Authors:  V Bruno; G Battaglia; A Kingston; M J O'Neill; M V Catania; R Di Grezia; F Nicoletti
Journal:  Neuropharmacology       Date:  1999-02       Impact factor: 5.250

Review 3.  Cerestat and other NMDA antagonists in ischemic stroke.

Authors:  K R Lees
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

Review 4.  Excitatory amino acids as a final common pathway for neurologic disorders.

Authors:  S A Lipton; P A Rosenberg
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

5.  17beta-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: a new neuroprotective pathway.

Authors:  A Mendelowitsch; M F Ritz; J Ros; H Langemann; O Gratzl
Journal:  Brain Res       Date:  2001-05-18       Impact factor: 3.252

6.  Effects of hyperosmolarity and ion substitutions on amino acid efflux from the ischemic rat cerebral cortex.

Authors:  J W Phillis; D Song; M H O'Regan
Journal:  Brain Res       Date:  1999-05-15       Impact factor: 3.252

7.  Multiple interstitial substances measured by microdialysis in patients with subarachnoid hemorrhage.

Authors:  F Staub; R Graf; P Gabel; M Köchling; N Klug; W D Heiss
Journal:  Neurosurgery       Date:  2000-11       Impact factor: 4.654

8.  Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil.

Authors:  A M Rao; J F Hatcher; R J Dempsey
Journal:  Neurosci Lett       Date:  2000-10-20       Impact factor: 3.046

9.  Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain.

Authors:  L Pellerin; G Pellegri; J L Martin; P J Magistretti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

10.  Steroid hormones use non-genomic mechanisms to control brain functions and behaviors: a review of evidence.

Authors:  F L Moore; S J Evans
Journal:  Brain Behav Evol       Date:  1999       Impact factor: 1.808

View more
  5 in total

1.  Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy.

Authors:  S Hariharan; V Bhardwaj; I Bala; J Sitterberg; U Bakowsky; M N V Ravi Kumar
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

2.  Glutamate-mediated excitotoxicity in neonatal hippocampal neurons is mediated by mGluR-induced release of Ca++ from intracellular stores and is prevented by estradiol.

Authors:  Genell D Hilton; Joseph L Nunez; Linda Bambrick; Scott M Thompson; Margaret M McCarthy
Journal:  Eur J Neurosci       Date:  2006-12       Impact factor: 3.386

Review 3.  Mechanisms of estrogens' dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia.

Authors:  Jakob O Strom; Annette Theodorsson; Elvar Theodorsson
Journal:  Int J Mol Sci       Date:  2011-02-25       Impact factor: 5.923

4.  Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases.

Authors:  Shameena Bake; Lijiang Ma; Farida Sohrabji
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

5.  In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain.

Authors:  Jason J Paris; Xi Chen; Joseph Anderson; Alaa N Qrareya; Fakhri Mahdi; Fei Du; Jay P McLaughlin; Marc J Kaufman
Journal:  Geroscience       Date:  2021-04-05       Impact factor: 7.713

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.